Sally Hodder, MD, professor of medicine, West Virginia Clinical and Translational Science Institute (WVCTSI) director, and associate vice president for clinical and translational research at West Virginia University, has been inducted into the West Virginia Health Care Hall of Fame by West Virginia Executive Magazine.
“It is an incredible honor to join the Health Care Hall of Fame,” said Hodder. “Having grown up in rural Ohio and then lucky enough to call West Virginia my home for the past six years, I remain passionate about ensuring the great people of this state have the same access to innovative research and clinical care as do people in major cities.”
Hodder and nine other honorees were selected in recognition of their direct impact on the health of all West Virginians. Since 2014, Hodder has directed WVCTSI, and worked tirelessly to address the state’s most pressing health disparities. In addition to the traditional health care areas WVCTSI addresses, Hodder has been leveraging her expertise as an infectious disease physician to combat the ongoing COVID-19 pandemic. To date, Hodder and the team at WVCTSI have brought $6 million in federal funding into West Virginia to combat this public health crisis through innovative research.
Dr. Hodder was nominated for this award by Clay Marsh, MD, vice president and executive dean for health sciences at WVU and West Virginia COVID-19 Czar.
"The future of medicine relies on our ability to be proactive and forward-thinking in our approaches to research and care," Dr. Marsh said. "Dr. Hodder's vision and her ability to connect people and groups to others has helped further the mission and vision of the School, our great state, and the field of medicine itself."
WVCTSI is funded by an IDeA Clinical and Translational grant from the National Institute of General Medical Sciences (U54GM104942) to support the mission of building clinical and translational research infrastructure and capacity to impact health disparities in West Virginia.